NEPHROS, INC. Proceeds from Issuance of Senior Long-term Debt
NEPHROS, INC. (NEPH) reported Proceeds from Issuance of Senior Long-term Debt of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt · last filed 2016-03-30
- NEPHROS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2014-12-31 was -$38.00K, a 102.53% decline year-over-year.
- NEPHROS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2014-09-30 was $1.61M.
- NEPHROS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2014-06-30 was $0.00.
- NEPHROS, INC. proceeds from issuance of senior long-term debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- NEPHROS, INC. proceeds from issuance of senior long-term debt for fiscal 2014 was $1.57M, a 43.86% decline from fiscal 2013.
- NEPHROS, INC. proceeds from issuance of senior long-term debt for fiscal 2013 was $2.80M.
| Period end | Proceeds from Issuance of Senior Long-term Debt 3 month | Proceeds from Issuance of Senior Long-term Debt 6 month | Proceeds from Issuance of Senior Long-term Debt 9 month | Proceeds from Issuance of Senior Long-term Debt 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 | |||
| 2014-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.57M derived: sum of 2 quarters · filed 2016-03-30 | $1.57M derived: sum of 3 quarters · filed 2016-03-30 | $1.57M 10-K · filed 2016-03-30 |
| 2014-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.61M derived: sum of 2 quarters · filed 2015-11-10 | $1.61M 10-Q · filed 2015-11-10 | $3.11M derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | $1.50M derived: sum of 3 quarters · filed 2015-04-15 | $1.50M derived: sum of 4 quarters · filed 2015-04-15 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $1.50M derived: sum of 2 quarters · filed 2015-04-15 | $1.50M derived: sum of 3 quarters · filed 2015-04-15 | $1.50M derived: sum of 4 quarters · filed 2015-04-15 |
| 2013-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $1.50M derived: sum of 2 quarters · filed 2015-04-15 | $1.50M derived: sum of 3 quarters · filed 2015-04-15 | $2.80M 10-K · filed 2015-04-15 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $1.30M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.30M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $1.30M 10-Q · filed 2014-05-14 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |